Table 1 . The demographic characteristics of the study population, prevalence of EE, GU, DU and positive urease test, the proportion of males among EE and PUD patients, according to the year of endoscopy.
| year | N | Age (Mean ± SD) in years | Male N (%) |
EE
N (%) |
GU
N (%) |
DU
N (%) |
Normal
N (%) |
Positive Urease test |
EE
Males (%) |
PUD Males (%) |
| 1993 | 106 | 39.6 ± 14.5 | 56 (52.8%) | 15 (14.1%) | 2 (1.8%) | 44 (41.5%) | 90 (84.9%) | 71.4% | 69.2% | 65.9% |
| 1994 | 453 | 39.8 ± 14.9 | 237 (52.3%) | 116 (25.6%) | 9 (2.0%) | 151 (33.3%) | 252 (55.6%) | 79.9% | 60.3% | 62.3% |
| 1995 | 629 | 39.7 ± 13.5 | 340 (54.1%) | 241 (38.3%) | 10 (1.6%) | 223 (35.5%) | 337 (53.6%) | 75.4% | 57.7% | 66.8% |
| 1996 | 832 | 39.9 ± 14.4 | 459 (55.2%) | 338 (40.6%) | 16 (1.9%) | 318 (38.2%) | 327 (39.3%) | 74.9% | 58.9% | 65.7% |
| 1997 | 971 | 40.2 ± 14.4 | 471 (48.5%) | 345 (35.5%) | 12 (1.2%) | 303 (31.2%) | 377 (38.8%) | 70.0% | 54.5% | 60.7% |
| 1998 | 905 | 41.5 ± 15.9 | 446 (49.3%) | 582 (64.3%) | 9 (1.0%) | 303 (33.5%) | 236 (26.1%) | 63.9% | 49.7% | 57.8% |
| 1999 | 800 | 40.1 ± 15.1 | 426 (53.2%) | 641 (80.1%) | 2 (0.3%) | 242 (30.3%) | 124 (15.5%) | 64.3% | 54.5% | 64.5% |
| 2000 | 660 | 41.0 ± 14.9 | 341 (51.7%) | 494 (74.8%) | 1 (0.2%) | 185 (28.0%) | 129 (19.5%) | 62.7% | 53.6% | 68.0% |
| 2001 | 521 | 41.9 ± 14.8 | 262 (50.3%) | 397 (76.2%) | 2 (0.4%) | 134 (25.7%) | 126 (24.2%) | 65.1% | 51.3% | 69.8% |
| 2002 | 380 | 42.8 ± 14.6 | 186 (48.9%) | 296 (77.9%) | 1 (0.3%) | 70 (18.4%) | 99 (26.1%) | 68.4% | 51.0% | 67.2% |
| 2003 | 634 | 41.9 ± 14.8 | 296 (46.7%) | 507 (80.0%) | 10 (1.6%) | 70 (11.1%) | 109 (17.2%) | 62.0% | 47.4% | 71.4% |
| 2004 | 668 | 42.4 ± 15.5 | 341 (51.0%) | 498 (74.6%) | 10 (1.5%) | 87 (13.0%) | 146 (21.9%) | 44.0% | 55.8% | 69.1% |
| 2005 | 470 | 44.2 ± 14.4 | 226 (48.1%) | 353 (75.1%) | 4 (0.9%) | 58 (12.3%) | 98 (20.8%) | 49.5% | 49.3% | 70.1% |
| Total | 8029 | 41.1 ± 14.9 | 4078 (50.9%) | 4808 (59.8%) | 88 (1.1%) | 2188 (27.3%) | 2450 (30.5%) | 65.3% | 53.1% | 63.0% |